Does T-cell lymphoma need surgery? Biopsy, vascular access, bowel procedures and cell collection

“The lymph node was removed, so why is more treatment needed?” “Does a stem cell transplant mean an operation to replace the marrow?” Several procedures may be called surgery in everyday conversation, although they serve very different purposes. For most systemic T-cell lymphomas, removal of a visible node supplies diagnostic tissue and does not establish that disease throughout the body has been eliminated. Certain specialised entities and acute complications do require a distinct surgical discussion.

Key takeaways

These excerpts come from the original article. Read the full sections below for context.

Lymphoma classification depends on tissue architecture and cellular features. An excisional or incisional biopsy can provide useful material when feasible; a core biopsy may be preferable for a deep or higher-risk location. The CAP guideline explains the limitations of fine-needle cytology alone and the need to match sampling to the diagnostic question. The largest operation is not automatically the best diagnostic procedure. CAP/ASCP: Laboratory Workup of Lymphoma in Adults guideline
Repeated intravenous treatment, blood sampling or supportive care may prompt discussion of an implanted port or another central venous catheter. A port lies beneath the skin and connects to a venous catheter; trained staff access it for use. MSK's patient information describes its structure and maintenance. Placement does not indicate that the lymphoma has become more advanced. Memorial Sloan Kettering: About Your Implanted Port
The useful record states what was done, what tissue was obtained, what device remains in place, who will review the patient and how the procedure affects the lymphoma plan. Different departments may perform the work, but their instructions should fit together. If restrictions appear inconsistent, ask the responsible teams to reconcile them before travel or the next treatment.

Quick answer

Full guide

Before a procedure, ask what it is intended to achieve, what its result will change and what alternatives exist. It may establish the diagnosis, provide a route for treatment, resolve a dangerous complication, treat a localised entity or collect cells for a larger treatment programme. Understanding the purpose explains why another step may still be necessary afterwards.

A diagnostic excision does not necessarily remove the entire illness

Lymphoma classification depends on tissue architecture and cellular features. An excisional or incisional biopsy can provide useful material when feasible; a core biopsy may be preferable for a deep or higher-risk location. The CAP guideline explains the limitations of fine-needle cytology alone and the need to match sampling to the diagnostic question. The largest operation is not automatically the best diagnostic procedure. CAP/ASCP: Laboratory Workup of Lymphoma in Adults guideline

Removing a whole node is different from demonstrating complete removal of a localised solid tumour. Integrated pathology and staging still determine the extent and subsequent treatment. A well-healed incision and a lymphoma remission describe different outcomes. Keep the procedure record identifying the exact sampled location so that future teams can compare it with imaging and other specimens.

Repeat sampling should answer a defined unresolved question

Transfer to another hospital may lead to slide review, additional stains or sampling of a new lesion. The ESMO–EHA guideline emphasises expert pathological diagnosis. New tissue can be valuable when the original material was insufficient or when the disease needs reassessment, including at relapse. If stored blocks and slides can answer the question, using them may avoid another invasive procedure. d’Amore et al.: ESMO–EHA guideline for peripheral T- and NK-cell lymphomas, 2025

Ask what information is missing, why existing material cannot provide it and how the new site was selected. Deep sampling requires discussion of anaesthesia, bleeding and organ-specific risks with the procedural team. Patients should not choose a target from their own scan or independently stop anticoagulants, antiplatelet medicines or diabetes treatment. The prescribing and procedural teams need to coordinate any changes.

Bowel involvement raises a separate surgical concern

Enteropathy-associated and monomorphic epitheliotropic intestinal T-cell lymphomas can affect bowel integrity. NCI discusses surgery in relation to diagnosis and perforation risk, along with bleeding, perforation and other complications during treatment. Whether to operate before systemic therapy, and how much bowel to remove, cannot be determined from the statement that lymphoma involves the intestine alone. NCI PDQ: Peripheral T-Cell Non-Hodgkin Lymphoma Treatment

Marked new abdominal pain, persistent vomiting, distension, bleeding or abdominal symptoms accompanied by systemic illness require timely assessment. Starting chemotherapy does not make every subsequent pain an expected side effect. Emergency clinicians need the disease location, recent treatment and immunosuppression history so that haematology and surgery can coordinate when necessary.

After a local danger is treated, the lymphoma plan still needs to reconnect with recovery. Clarify who will integrate the pathology, wound healing, nutrition, infection control and timing of further therapy. If a temporary stoma is needed, ask about care support and later reassessment. A fixed reversal date cannot be guaranteed before recovery and disease control are known.

Implant-associated ALCL is a particular exception

Breast implant-associated ALCL often involves peri-implant fluid or the surrounding capsule. FDA information describes removal of the implant and capsule as part of treatment, with additional therapy needed in some circumstances. The disease entity and extent must be established before defining the surgical objective; this differs from simply excising a node in a systemic T-cell lymphoma. FDA: Questions and Answers about Breast Implant-Associated ALCL

A late fluid collection needs appropriate sampling and pathological evaluation. Draining it does not by itself settle the cause. In confirmed disease, the surgical record, capsule pathology and extent assessment inform subsequent management. For people with implants but no symptoms, FDA does not recommend universal routine removal. Treatment of a confirmed case and preventive removal in an asymptomatic person are separate questions.

Ports and other venous lines provide access

Repeated intravenous treatment, blood sampling or supportive care may prompt discussion of an implanted port or another central venous catheter. A port lies beneath the skin and connects to a venous catheter; trained staff access it for use. MSK's patient information describes its structure and maintenance. Placement does not indicate that the lymphoma has become more advanced. Memorial Sloan Kettering: About Your Implanted Port

Selection depends on expected use, medicines, peripheral veins and access to care at home. A port, a PICC and a line suitable for apheresis are not necessarily interchangeable. If a device is already in place, provide its type, insertion date and related records so that the next team can check suitability. A transfer does not automatically justify replacement.

Report redness, discharge, pain, unusual arm or neck swelling, fever, chills or problems during infusion. Do not independently flush, remove or force a blocked line. Maintenance needs trained personnel and an individual schedule from the responsible service. A generic interval from an online article should not override instructions for the actual device and patient.

Stem cell collection usually does not mean an operation on the marrow

For an autologous transplant, mobilisation can increase the number of blood-forming stem cells circulating in the bloodstream. Apheresis equipment then collects the required cells and returns the remaining blood components. MSK's collection guide describes this process. The collection team determines whether arm veins are sufficient or a specialised line is required. Memorial Sloan Kettering: Autologous Peripheral Blood Stem Cell Harvesting, 2026

The number of sessions depends on the collected cell yield and treatment requirements; one-session success cannot be promised. Tingling around the mouth or fingers, twitching or other symptoms during collection should be reported immediately so staff can assess and manage possible electrolyte changes. Patients should not alter mobilisation drugs or add supplements based on a general description. Collected cells enter a controlled storage process, rather than being carried by the patient in an ordinary cooler.

Collection is not the completed transplant. Conditioning, cell infusion, blood-cell recovery and complication management follow according to the plan. NCI distinguishes autologous and allogeneic sources and risks. Cells are commonly infused intravenously; a piece of marrow is not surgically fitted into the recipient. The required care extends beyond a single procedure date. NCI: Stem Cell Transplants in Cancer Treatment

Reassessment can occur between collection and transplantation

Response, infection and organ function can change whether the original plan remains appropriate. The EBMT Handbook considers transplantation in the context of specific T-cell entities and disease status. Scheduling collection therefore does not replace continued assessment of the indication. If the plan changes, the clinical reason should be recorded so the patient understands what has changed. Hübel et al.: Other B- and T-Aggressive Lymphomas, EBMT Handbook 2024

International patients travelling to China should establish whether the proposed service covers assessment, collection or the whole transplant course. Estimates of cost and stay need the same scope. Any transfer of cellular material between institutions involves quality controls, documentation and receiving requirements that the centres must coordinate. Two services both describing themselves as stem cell centres does not prove that they can exchange a product without further arrangements.

Nutrition, mouth care and infection affect recovery

After bowel surgery, with poor intake or before intensive treatment, nutritional assessment can help select suitable support. NCI's nutrition guidance bases management on symptoms, absorption and treatment circumstances. Taking more supplements is not a universal solution. Some patients need modified food texture or professional nutritional support, with the method determined by the clinical team. NCI PDQ: Nutrition in Cancer Care

Report dental disease, oral infection and mucosal problems before planned intensive treatment. NCI's oral-complication guidance discusses assessment and continued care. Invasive dental work must account for blood counts, timing and healing; it should not be arranged independently during significant cytopenia. Coordination prevents one procedure from creating an avoidable problem for another phase of care. NCI PDQ: Oral Complications of Cancer Therapies

Fever, chills or wound changes during immunosuppression should not be dismissed as routine postoperative effects. NCI explains that infection can require urgent assessment. A holiday or impending return flight should not be a reason to wait. Discharge information should include wound or line care, concerning symptoms and a contact route, rather than only a statement that the operation went well. NCI: Infection and Neutropenia during Cancer Treatment

Obtain a record that connects the procedure to the next step

The useful record states what was done, what tissue was obtained, what device remains in place, who will review the patient and how the procedure affects the lymphoma plan. Different departments may perform the work, but their instructions should fit together. If restrictions appear inconsistent, ask the responsible teams to reconcile them before travel or the next treatment.

For example, a surgical wound review and a haematology appointment may answer different questions. Keeping both does not represent duplicate care. Conversely, two separate device-maintenance schedules may need clarification. A patient should know which service owns each task and which clinician can resolve a problem that crosses departmental boundaries. This makes the procedural part of treatment understandable without assuming that every intervention is intended to cure the lymphoma by itself.